Green algae have garnered attention in recent years due to their potential applications in biotechnology, offering solutions in areas such as biofuel production, wastewater treatment, and pharmaceuticals. Certain species of green algae are rich in lipids, making them suitable candidates for biodiesel production. Researchers are exploring ways to optimize cultivation conditions and lipid extraction methods to enhance the efficiency of biofuel production from green algae. The ability of green algae to absorb and accumulate heavy metals has led to their use in phytoremediation, a process where plants and algae are employed to remediate contaminated environments. Green algae can absorb pollutants from water, soil, or air, contributing to environmental cleanup efforts. Moreover, green algae serve as valuable sources of bioactive compounds with potential pharmaceutical applications. Compounds such as carotenoids, polyphenols, and polysaccharides derived from green algae have demonstrated antioxidant, anti-inflammatory, and antiviral properties. Ongoing research explores the therapeutic potential of these compounds in the development of novel drugs and nutraceuticals. The diverse applications of green algae in biotechnology highlight their versatility and potential contributions to addressing environmental and health-related challenges. As research advances, the exploitation of green algae for sustainable solutions continues to expand, showcasing their significance beyond their ecological role.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation